22 March 2024
iStock/ViktorCapBy Sarah Lowden
Thousands of patients in England with suspected lung cancer are to be offered a blood test which can indicate if they can receive treatment earlier and have targeted therapies.
NHS England said the circulating tumour DNA (ctDNA) test, which will be offered to 10,000 patients by next March, can identify genetic variants in a tumour through a blood sample.